Benjamin Bruno Thorner - 04 Feb 2026 Form 3 Insider Report for Eikon Therapeutics, Inc. (EIKN)

Role
General Counsel and Chief Business Officer Exhibit List - Exhibit 24 - Power of Attorney
Signature
/s/ Benjamin Thorner
Issuer symbol
EIKN
Transactions as of
04 Feb 2026
Net transactions value
$0
Form type
3
Filing time
04 Feb 2026, 21:18:12 UTC
Next filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Thorner Benjamin Bruno General Counsel and Chief Business Officer Exhibit List - Exhibit 24 - Power of Attorney C/O EIKON THERAPEUTICS, INC., 230 HARRIET TUBMAN WAY, MILLBRAE /s/ Benjamin Thorner 04 Feb 2026 0002102118

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EIKN Stock Option (Right to Buy) 04 Feb 2026 Common Stock 127,383 $9.85 Direct F1
holding EIKN Stock Option (Right to Buy) 04 Feb 2026 Common Stock 26,817 $9.85 Direct F1
holding EIKN Stock Option (Right to Buy) 04 Feb 2026 Common Stock 30,169 $9.85 Direct F1
holding EIKN Stock Option (Right to Buy) 04 Feb 2026 Common Stock 83,804 $9.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option will vest in equal monthly installments for four years after the vesting starting date, subject to the Reporting Person's continued service through each date.

Remarks:

General Counsel and Chief Business Officer Exhibit List - Exhibit 24 - Power of Attorney